Description
TIRZ – 30mg delivers a high-purity form of Tirzepatide, specifically formulated for laboratory and scientific research. Tirzepatide is a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, making it a focal point in the study of metabolic conditions such as type 2 diabetes and obesity.
Ongoing research suggests that Tirzepatide may influence insulin release, support glycemic control, and promote weight reduction in experimental models by mimicking key hormonal pathways involved in glucose metabolism.
This 30mg option provides flexible dosing for a range of lab protocols and is produced under rigorous quality standards to ensure purity and consistency.
For Research Use Only
TIRZ – 30mg is not intended for human or veterinary use. This product is exclusively for in vitro and laboratory research by trained professionals.
